P2Y(12) Inhibitor Monotherapy after Percutaneous Coronary Intervention

In patients with acute and chronic coronary artery disease undergoing percutaneous coronary intervention (PCI), dual antiplatelet therapy (DAPT) has been the cornerstone of pharmacotherapy for the past two decades. Although its antithrombotic benefit is well established, DAPT is associated with an i...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xuan, Angiolillo, Dominick J., Ortega-Paz, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604207/
https://www.ncbi.nlm.nih.gov/pubmed/36286292
http://dx.doi.org/10.3390/jcdd9100340

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604207/
https://www.ncbi.nlm.nih.gov/pubmed/36286292
http://dx.doi.org/10.3390/jcdd9100340

Ejemplares similares